Mechanisms of SGLT2 Inhibition in Pediatric Steatotic Liver Disease
Mechanisms of SGLT2 Inhibition in Pediatric Steatotic Liver Disease
Recruiting · NCT06355310 · Registry updated 2026-01-21Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Mechanisms of SGLT2 Inhibition in Pediatric Steatotic Liver Disease | Digestive System Diseases, fatty liver disease, liver disorder, metabolic dysfunction-associated steatotic liver disease | Recruiting | Phase 2 | 2026-01-21 | NCT06355310 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Justin Ryder | 2 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Ann & Robert H Lurie Children's Hospital of Chicago | Chicago | United States | 14 |